View Older Stories View More Recent Stories
-
Hinge Health Inc (HNGE) PT Lowered to $52 at Barclays
-
Hinge Health, Inc. (HNGE) Tops Q4 EPS by 35c, provides guidance
-
Hinge Health (HNGE) Reiterated at Market Outperform by Citizens After Due Diligence
-
Freedom Capital Markets Starts Hinge Health Inc (HNGE) at Buy
-
Canaccord Genuity Reiterates Buy Rating on Hinge Health Inc (HNGE)
-
Hinge Health (HNGE) Reiterated at Buy by Stifel: Launches Digital-First Model
-
Hinge Health Inc (HNGE) PT Lowered to $60 at Piper Sandler
-
Wells Fargo Starts Hinge Health Inc (HNGE) at Overweight
-
Needham on Hinge Health Inc (HNGE): 2026 Health Tech Top Pick
-
Hinge Health's (HNGE) US Moat Will Drive Durable Growth - Citizens
-
Hinge Health (HNGE) Has Attractive Financial Profile - Citizens
-
Truist on Hinge Health Inc (HNGE): 'Assessing HingeSelect's Potential as Another Growth Engine'
-
Citizens Reiterates Market Outperform Rating on Hinge Health Inc (HNGE)
-
Hinge Health Inc (HNGE) PT Raised as Truist Sees 'An Attractive Buying Opportunity'
-
Hinge Health Inc (HNGE) PT Raised at Piper Sandler Following a 'Strong 3Q25 Beat'
-
Hinge Health Inc (HNGE) PT Raised to $72 at Morgan Stanley
-
Hinge Health, Inc. (HNGE) Tops Q3 EPS by 19c
-
Hinge Health launches AI tools for movement tracking and patient support
-
Piper Sandler Reiterates Overweight Rating on Hinge Health Inc (HNGE), 'We Would Be Buyers of This Dip'
-
Hinge Health Inc (HNGE) PT Raised to $66 at Stifel
-
Baird Starts Hinge Health Inc (HNGE) at Neutral, 'we are adopting a relatively cautious stance'
-
Piper Sandler Reiterates Overweight Rating on Hinge Health Inc (HNGE)
-
Hinge Health Inc (HNGE) PT Raised to $70 at Piper Sandler
-
Tiger Global Updates 13F, Adds 5 New Holdings
-
Hinge Health Inc (HNGE) PT Raised to $63 at Stifel
-
Hinge Health Inc (HNGE) PT Raised to $60 at Evercore ISI
-
Hinge Health Inc (HNGE) PT Raised to $65 at Citizens JMP
-
Hinge Health, Inc. (HNGE) Reports Q2 Loss of $13.10, provides guidance
-
Citizens JMP Starts Hinge Health Inc (HNGE) at Market Outperform
-
Truist: 'Hinge Health Inc (HNGE) Is Our Preferred Name in the Employer Benefits Market'
-
Truist Securities Reiterates Buy Rating on Hinge Health Inc (HNGE) Following HingeSelect Launch
-
Wall Street analysts start with bullish ratings on Hinge Health on growth potential
-
BofA Securities Starts Hinge Health Inc (HNGE) at Buy
-
Raymond James Starts Hinge Health Inc (HNGE) at Outperform
-
Needham Starts Hinge Health Inc (HNGE) at Buy
-
Evercore ISI Starts Hinge Health Inc (HNGE) at Outperform
-
Canaccord Genuity Starts Hinge Health Inc (HNGE) at Buy
-
William Blair Starts Hinge Health Inc (HNGE) at Outperform
-
Barclays Starts Hinge Health Inc (HNGE) at Overweight
-
Truist Securities Starts Hinge Health Inc (HNGE) at Buy
-
Piper Sandler Starts Hinge Health Inc (HNGE) at Overweight
-
Morgan Stanley Starts Hinge Health Inc (HNGE) at Overweight
-
RBC Capital Starts Hinge Health Inc (HNGE) at Outperform
-
Stifel Starts Hinge Health Inc (HNGE) at Buy
-
KeyBanc Starts Hinge Health Inc (HNGE) at Overweight
-
Hinge Health IPO surges 23% on debut
-
Hinge Health (HNGE) IPO opens at $39.25 after pricing at $32
-
Hinge Health (HNGE) Files Registration Statement for Proposed IPO
-
Hinge Health (HNGE) Files for Proposed IPO

